EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
51 hedge funds and large institutions have $70.4M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$367K | |
| 2 | +$323K | |
| 3 | +$234K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$153K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$137K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$580K | |
| 3 | -$201K | |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$67K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.69K |